Mirae Asset Global Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483K | Buy |
|
|||||
|
2025
Q1 | $548K | Buy |
|
|||||
|
2024
Q4 | $507K | Sell |
|
|||||
|
2024
Q3 | $593K | Buy |
|
|||||
|
2024
Q2 | $604K | Sell |
|
|||||
|
2024
Q1 | $9.83M | Buy |
|
|||||
|
2023
Q4 | $4.95M | Sell |
|
|||||
|
2023
Q3 | $9.05M | Buy |
|
|||||
|
2023
Q2 | $8.75M | Sell |
|
|||||
|
2023
Q1 | $19.6M | Buy |
|
|||||
|
2022
Q4 | $10.7M | Sell |
|
|||||
|
2022
Q3 | $10.3M | Buy |
|
|||||
|
2022
Q2 | $8.99M | Sell |
|
|||||
|
2022
Q1 | $10.7M | Sell |
|
|||||
|
2021
Q4 | $14.4M | Buy |
|
|||||
|
2021
Q3 | $11.6M | Buy |
|
|||||
|
2021
Q2 | $10.1M | Buy |
|
|||||
|
2021
Q1 | $7.09M | Buy |
|
|||||
|
2020
Q4 | $5.14M | Sell |
|
|||||
|
2020
Q3 | $5.71M | Buy |
|
|||||
|
2020
Q2 | $7.35M | Buy |
|
|||||
|
2020
Q1 | $4.11M | Buy |
|
|||||
|
2019
Q4 | $3.52M | Buy |
|
|||||
|
2019
Q3 | $2.27M | Buy |
|
|||||
|
2019
Q2 | $2.23M | Buy |
|
|||||
|
2019
Q1 | $1.94M | Buy |
|
|||||
|
2018
Q4 | $1.69M | Buy |
|
|||||
|
2018
Q3 | $1.66M | Buy |
|
|||||
|
2018
Q2 | $1.27M | Buy |
|
|||||
|
2018
Q1 | $951K | Buy |
|
|||||
|
2017
Q4 | $1.01M | Buy |
|
|||||
|
2017
Q3 | $963K | Buy |
|
|||||
|
2017
Q2 | $727K | Buy |
|
|||||
|
2017
Q1 | $569K | Buy |
|
|||||
|
2016
Q4 | $235K | Sell |
|
|||||
|
2016
Q3 | $437K | Sell |
|
|||||
|
2016
Q2 | $494K | Buy |
|
|||||
|
2016
Q1 | $505K | Buy |
|
|||||
|
2015
Q4 | $612K | Buy |
|
|||||
|
2015
Q3 | $448K | Buy |
|
|||||
|
2015
Q2 | $559K | Buy |
|
|||||
|
2015
Q1 | $474K | Buy |
|
|||||
|
2014
Q4 | $316K | Buy |
|
|||||
|
2014
Q3 | $252K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $578K | Buy |
|